Pesquisas alternativas:
disease devel » disease level (Expandir a Pesquisa), disease develop (Expandir a Pesquisa), disease levels (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
level theory » legal theory (Expandir a Pesquisa), model theory (Expandir a Pesquisa), cell theory (Expandir a Pesquisa)
nurse level » nurses level (Expandir a Pesquisa), nursery level (Expandir a Pesquisa), nurses levels (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
level ther » level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa), level three (Expandir a Pesquisa)
drug nurse » drug noise (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 684 para a pesquisa '(( drug disease devel ther ) OR ((( drug de level ther ) OR ( drug nurse level theory ))))*', tempo de pesquisa: 1.26seg Refinar resultados
Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays

Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application

Disease-modifying drugs in Alzheimer’s disease
Future of Automated Insulin Delivery Systems

The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes
Prognostic factors in patients with pancreatic cancer

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy

Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains

Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis
HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa